SCHEMBL4903873

SCHEMBL4903873

CCN(c1coc(-c2ccc(C(F)(F)F)cc2)n1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.38
PPARG P37231 6/20 0.36
PPARA Q07869 6/20 0.36
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RORC P51449 2/20 0.35
HDAC3 O15379 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GAA P10253 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
HSP90AA1 P07900 1/20 0.34
MAPT P10636 1/20 0.34
CRHBP P24387 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895724 0.92 PPARG (0.38) HDAC8PPARGPPARASMN1; SMN2HDAC3
SCHEMBL4911906 0.91 HDAC8 (0.39) HDAC8PPARGPPARAUSP2SMN1; SMN2
SCHEMBL4906847 0.91 ALDH1A1 (0.38) HDAC8PPARGPPARAUSP2SMN1; SMN2
SCHEMBL4903608 0.87 PPARG (0.41) HDAC8PPARGPPARAUSP2SMN1; SMN2
SCHEMBL4907412 0.83 HCRTR2 (0.36) HDAC8PPARGPPARAHDAC3HDAC11
SCHEMBL4906508 0.83 LMNA (0.41) HDAC8PPARGPPARAUSP2SMN1; SMN2
SCHEMBL4895643 0.83 HDAC8 (0.53) HDAC8PPARGPPARARORCHDAC3
SCHEMBL4900715 0.83 ALDH1A1 (0.39) HDAC8PPARGPPARASMN1; SMN2HDAC3
SCHEMBL4900885 0.80 PPARG (0.43) HDAC8PPARGPPARAUSP2SMN1; SMN2
SCHEMBL4900544 0.80 KDM4E (0.41) HDAC8PPARGPPARARORCHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD HDAC8 959/4885PPARG 2/4885PPARA 1/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HDAC8 882/4885PPARG 2/4885PPARA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.